February 19, 2009FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events FDA and International Serious Adverse Events Consortium Release First Data on Genetic Basis of Adverse Drug Events
The first data offering health care professionals a better look into the genetic basis of certain types of adverse drug events was released today by the FDA and the International Serious Adverse Event Consortium (SAEC). The data are focused on the genetics associated with drug-induced serious skin rashes, such as Stevens-Johnson syndrome and toxic epidermal necrolysis, and helps better predict an individual's risk of developing these reactions. Source: www.fda.gov # posted by Network @ 12:29 PM
 |
Subscribe to Posts [Atom]